A Phase 1 interventional study of ACT-541468 and Suvorexant in Healthy Recreational Drug Users, sponsored by Idorsia Pharmaceuticals Ltd.. Completed at 2 sites in 2 countries. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-19.
Sponsored by Idorsia Pharmaceuticals Ltd. · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This placebo- and active controlled study will investigate the abuse potential of ACT-541468 in healthy recreational drug users
Idorsia Pharmaceuticals Ltd. is the lead sponsor of 103 studies on the registry; 4 are open to participants now.
Of its 29 completed or terminated interventional studies of FDA-regulated products, 9 (31%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Any of the following SLEEP-50 Questionnaire scores at Screening:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.
Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hepatitis B tests
Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.
Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ACT-541468 will be administered as tablets for oral use.
Drug: ACT-541468
ACT-541468 will be administered as tablets for oral use.
Drug: ACT-541468
ACT-541468 will be administered as tablets for oral use.
Drug: ACT-541468
Suvorexant will be administered as tablets for oral use.
Drug: Suvorexant
Zolpidem will be administered as tablets for oral use.
Drug: Zolpidem
Placebo will be administered as tablets for oral use.
Drug: Placebo
ACT-541468 will be administered as 50 mg tablets for oral use.
Suvorexant will be administered as 15 mg over-encapsulated tablets for oral use.
Zolpidem will be administered as 10 mg over-encapsulated tablets for oral use.
Matching-placebo will be used.
Maximum effect (Emax) of the Drug Liking VAS ('at this moment') over 24 h post-dose during each treatment period
VAS = visual analogue scale
Time frame: Duration: for up to 24 hours post-dose
Drug Liking VAS (bipolar)
VAS = visual analogue scale
Time frame: Duration: for up to 24 hours post-dose
Overall Drug Liking VAS (bipolar)
VAS = visual analogue scale
Time frame: Duration: for up to 12 hours post-dose
Take Drug Again VAS (bipolar)
Time frame: Duration: for up to 12 hours post-dose
Good Effects VAS (unipolar)
Time frame: Duration: for up to 24 hours post-dose
Drug Similarity VAS
VAS = visual analogue scale
Time frame: Duration: for up to 1 hour post-dose
Bad Effects VAS (unipolar)
VAS = visual analogue scale
Time frame: Duration: for up to 24 hours post-dose
Alertness/Drowsiness VAS (bipolar)
VAS = visual analogue scale
Time frame: Duration: for up to 24 hours post-dose
Any Effects VAS (unipolar)
VAS = visual analogue scale
Time frame: Duration: for up to 24 hours post-dose
Feeling High VAS (unipolar)
VAS = visual analogue scale
Time frame: Duration: for up to 24 hours post-dose
Bowdle VAS Internal and External Perceptions
Time frame: Duration: for up to 24 hours post-dose
Observer's Assessment of Alertness/Sedation composite and sum scores
Time frame: Duration: for up to 24 hours post-dose
Reaction time task score
Time frame: Duration: for up to 8 hours post-dose
Rapid visual information processing score
Time frame: Duration: for up to 8 hours post-dose
Paired Associates Learning score
Time frame: Duration: for up to 8 hours post-dose
AUC(0-t) of ACT-541468
Time frame: Duration: for up to 24 hours post-dose
AUC(0-∞) of ACT-541468
Time frame: Duration: for up to 24 hours post-dose
Cmax of ACT-541468
Time frame: Duration: for up to 24 hours post-dose
tmax of ACT-541468
Time frame: Duration: for up to 24 hours post-dose
t½ of ACT-541468
Time frame: Duration: for up to 24 hours post-dose
Treatment-emergent adverse events (AEs)
Time frame: All AEs from (first) admittance on Day -1 up to EOS, i.e. for up to 9 weeks
Treatment-emergent serious AEs (SAEs)
Time frame: SAE reporting: from signature of informed consent up to EOS, i.e. for up to 13 weeks
Plan to share: No
Ran from Sep 2018 to primary completion in Aug 2019, 11 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Daridorexant
Idorsia Pharmaceuticals Ltd. →